Beam lays off 20% of staff and culls CAR-T work to save cash – FierceBiotech

  1. Beam lays off 20% of staff and culls CAR-T work to save cash FierceBiotech
  2. Beam Therapeutics Announces Portfolio Prioritization and Strategic Restructuring Focused on Potential Near-term Value Drivers and Long-term Growth of Precision Genetic Medicines Pipeline GlobeNewswire
  3. Beam Therapeutics cuts 100 jobs The Boston Globe
  4. StockWatch: For Genome Editing, Inflection Points Crowd the Calendar Genetic Engineering & Biotechnology News
  5. Beam Therapeutics to lay off 20% of its staff, reevaluate programs as it cuts costs STAT
  6. View Full Coverage on Google News

Read original article here

Leave a Comment